FDA UDI In Commercial Distribution 🇺🇸 United States

Genio System 2.1

DI: 05404031000049 · Model: Genio Smartphone Application Software · Nyxoah
Product Codes
1
GMDN Terms
1
Identifiers
1
Pkg Device Count
1

Basic Information

Brand Name
Genio System 2.1
Primary DI
05404031000049
Version / Model
Genio Smartphone Application Software
Company Name
Nyxoah
Labeler DUNS
400460590
Distribution Status
In Commercial Distribution
Device Count in Pkg
1
Record Status
Published
Publish Date
2025-08-26
Public Version
1
Public Version Date
2025-09-03
Public Version Status
New
Public Device Record Key
8edd5aad-b623-4334-a05a-97509cca512e

Device Description

The Activation Chip can be controlled by an optional Genio Smartphone Application software, designed to operate on both Android and iOS devices. The Smartphone Application software allows the patient to pause and resume stimulation and to increase/decrease the treatment amplitude within a pre-configured range. The Smartphone Application software uses Bluetooth low energy (BLE) protocol to communicate with a paired Activation Chip.

Device Characteristics

Single Use
No
Prescription Use (Rx)
Yes
Over the Counter (OTC)
No
Kit
No
Combination Product
No
HCT/P
No
Contains NRL
No
Not Made with NRL
No
MRI Safety
Labeling does not contain MRI Safety Information
Direct Marking Exempt
No
PM Exempt
No
Has Serial Number
Yes
Has Lot/Batch Number
No
Has Manufacturing Date
No
Has Expiration Date
No
Has Donation ID
No

Sterilization

Is Sterile
No
Sterilization Prior Use
No

Product Codes

Code Name
MNQ Stimulator, Hypoglossal Nerve, Implanted, Apnea

GMDN Terms

Code Name
60360 Implantable sleep apnoea treatment system, fixed-rate

Identifiers

Type ID
Primary 05404031000049

Premarket Submissions

Submission Number Supplement Number
P240024 000